TCL Archive NCCN’s First Physician CEO: Robert Carlson Pledges Broader Research and Policy Agenda October 5, 2012
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive In Brief: DeVita Vs. Lincoln; ACS Says It Will Take “New Initiatives In Political Forums” March 17, 1978
TCL Archive In Brief : Three Named To Leadership Posts At St. Jude; Mitchell Weiss Appointed Chair of Hematology July 11, 2014
